Key in-hospital and discharge medications
| Medication . | n (%) . | |
|---|---|---|
| In hospital . | Discharge . | |
| IL-6 antagonists* | 2762 (56.3) | 262 (5.3) |
| Hydroxychloroquine | 2728 (55.6) | 262 (5.3) |
| Statins | 1500 (30.6) | 135 (2.8) |
| Aspirin | 1073 (21.9) | 91 (1.9) |
| Other antiplatelets† | 279 (5.7) | 29 (0.6) |
| Famotidine | 699 (14.3) | 65 (1.3) |
| Antibiotics | 517 (10.5) | 31 (0.6) |
| Anakinra | 295 (6.0) | 0 (0.0) |
| Antivirals | 98 (2.0) | 1 (0.02) |
| IV immunogloblin | 26 (0.5) | 0 (0.0) |
| Glucocorticoids | 1329 (27.1) | 118 (2.4) |
| Medication . | n (%) . | |
|---|---|---|
| In hospital . | Discharge . | |
| IL-6 antagonists* | 2762 (56.3) | 262 (5.3) |
| Hydroxychloroquine | 2728 (55.6) | 262 (5.3) |
| Statins | 1500 (30.6) | 135 (2.8) |
| Aspirin | 1073 (21.9) | 91 (1.9) |
| Other antiplatelets† | 279 (5.7) | 29 (0.6) |
| Famotidine | 699 (14.3) | 65 (1.3) |
| Antibiotics | 517 (10.5) | 31 (0.6) |
| Anakinra | 295 (6.0) | 0 (0.0) |
| Antivirals | 98 (2.0) | 1 (0.02) |
| IV immunogloblin | 26 (0.5) | 0 (0.0) |
| Glucocorticoids | 1329 (27.1) | 118 (2.4) |